Pune, India – September 25, 2026 -- The global AI in Clinical Trials Market is set to more than triple from USD 2 billion in 2025 to USD 7.32 billion by 2034, expanding at a 15.5% compound annual growth rate, according to Maximize Market Research.

Hopewell, N.J. – September 18, 2026 -- ProBio, a global contract development and manufacturing organization (CDMO), has struck a strategic collaboration with Kun Tuo, an IQVIA-owned clinical research organization (CRO) in China, to integrate manufacturing and clinical trial execution for advanced therapies.